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Abstract
Background: Despite the clear policy intent to contain it, the marketing of formula milk remains widespread,
powerful and successful. This paper examines how it works.
Methods: The study comprised a mix of secondary analysis of business databases and qualitative interviews with
marketing practitioners, some of whom had previously worked in formula marketing.
Results: The World Health Assembly Code aims to shield parents from unfair commercial pressures by stopping the
inappropriate promotion of infant formula. In reality marketing remains widespread because some countries (e.g.
the USA) have not adopted the Code, and elsewhere industry has developed follow-on and specialist milks with
which they promote formula by proxy. The World Health Assembly has tried to close these loopholes by extending
its Code to these products; but the marketing continues. The campaigns use emotional appeals to reach out to and
build relationships with parents and especially mothers. Evocative brands give these approaches a human face. The
advent of social media has made it easier to pose as the friend and supporter of parents; it is also providing
companies with a rich stream of personal data with which they hone and target their campaigns.
The formula industry is dominated by a small number of extremely powerful multinational corporations with the
resources to buy the best global marketing expertise. Like all corporations they are governed by the fiduciary
imperative which puts the pursuit of profits ahead of all other concerns. This mix of fiscal power, sophisticated
marketing, and single-mindedness is causing great harm to public health.
Conclusions: Formula marketing is widespread and using powerful emotional techniques to sell parents a product
that is vastly inferior to breast milk. There is an urgent need to update and strengthen regulation.
Keywords: Commercial determinants of ill-health, Infant formula, Breast milk substitutes, Marketing, Multinational
corporations, Corporate power
Background
The commercial determinants of ill-health are now well
recognised. In particular, many of the products we con-
sume – tobacco, processed food, alcohol, petrochemicals,
leaded paint, guns – are known to have caused such harm,
even when used as intended, that a new descriptor, the ‘in-
dustrial epidemic’ [1], has been coined. Whilst free choice
and consumer sovereignty are much lauded, in reality this
destructive consumption behaviour is not altogether vol-
untary; we are energetically encouraged to smoke, drive
cars and arm ourselves by those who gain from our self-
harm - the companies that make and sell these products.
In recent years these industries have grown in size, led by
multinational corporations with powerful lobbying and
corporate affairs functions with which to engage policy
makers. So, soda makers can influence the Centers for
Disease Control and Prevention [2], oil companies under-
mine climate science [3] and the paint industry exonerate
lead [4], and in the process regulation is avoided, delayed
or contained.
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This ensures an environment where marketing – the
persuasive tool of choice for consumers – can be used
with maximum efficiency. Its capacity to encourage con-
sumption has been established in multiple studies for to-
bacco, alcohol and processed food [5–7]. The methods
used by marketers have also been examined, and the role
of emotional appeals, branding and careful targeting noted
[5]. The advent of digital technologies has raised further
concerns about the insidious power of social media mar-
keting, and the bespoke, deep messaging it facilitates.
Facebook gets over 98% of its income from advertising [8],
and the Cambridge Analytica revelations show how perva-
sive and profound digital influence has become [9].
This paper concerns an industrial epidemic that has
been going on for four decades in the infant feeding do-
main: the breast milk substitutes (BMS) industry. A recent
analysis shows that if all babies were breastfed as the
World Health Organization (WHO) recommends, over
800,000 infant deaths would be avoided each year [10].
BMS also harm the intellectual development of the baby
to such an extent that it is possible to detect the impact
on GDP of a predominantly bottle-fed population [11]. In
addition, there is an increased risk of breast cancer for the
mother [10], and significant ecological harm: packaging,
supply chains and bottle-feeding apparatus all have a car-
bon footprint and introduce durable plastics into the en-
vironment [11]. The competition, breast milk, has none of
these drawbacks, and comes with natural antibodies that
turn it into “a personalised medicine for infants” [10];
manufactured products cannot begin to replicate these
benefits. Breast milk is also much cheaper. Bottle feeding
a baby for six months in the UK today costs £175 (approx.
US$210) for the cheapest own-label products, and more
than double that for a premium brand [12], and these fig-
ures do not include any equipment, such as bottles, teats
and sterilisers. Comparable data from the USA suggest
that it could cost between US$451 and $810 to buy BMS
product to feed a baby for six months [13]. There are
some advantages to bottle-feeding: for some women,
breastfeeding can be difficult to instigate and maintain so
formula is a necessary alternative; conflicts can arise (for
mothers or observers) between the feeding and sexual
functions of the breast; and unsupportive public and work
places make breastfeeding difficult. The fact that breast-
feeding is not readily accommodated by the world of work
worldwide makes it particularly challenging for women to
breastfeed in the absence of or beyond any period of ma-
ternity leave. This is a marked problem in low-income
countries where welfare systems are less well-developed.
However, in most cases, when taken in the context of
threats to the baby’s life and future prospects, or the risk
of cancer, these benefits become much less persuasive.
Selling a product which falls so far behind the compe-
tition seems challenging, but the evidence shows it can
and is being done with remarkable success. Marketing
has, as with other health harming products, been proven
to encourage formula consumption [14] and sales are in-
creasing 8% year-on-year; the global market for BMS
products was forecast to reach US$70.7 billion by 2019
[11]. Across the world, in high- and low-income coun-
tries alike, only 40% of mothers now follow WHO
breastfeeding guidelines [15].
Concerns about the marketing of infant formula are
not new. Forty years ago, the World Health Assembly
(WHA; the decision-making body of the world’s Mem-
ber States) developed its International Code of Market-
ing of Breast-milk Substitutes [16] which required
companies to acknowledge the superiority of breast milk,
and outlawed any advertising or promotion of BMS to
the general public. In reality, marketing remains wide-
spread because some countries (e.g. the USA) have not
adopted the Code and elsewhere industry has developed
follow-on and specialist milks which they use to pro-
mote infant formula by proxy – that is, they are branded
in exactly the same way and the boundaries between in-
fant formula and follow-on and other products are
blurred. The WHA has moved to close these loopholes
by clarifying that the Code also applies to these products
[17]; but the marketing continues. The advent and pro-
liferation of digital media has further undermined the
Code.
This study was designed to understand how BMS for-
mula marketers have succeeded, despite the known in-
feriority of their product in comparison with breast milk
and the exigencies of the Code. Their methods have pre-
viously been audited and described [16, 18–22]; we
aimed to analyse and explain them.
Methods
We used a mixed methods approach involving two
linked data collection exercises: a review of publicly
available data on the global marketing of breast milk
substitutes, followed by qualitative interviews with mar-
keting practitioners with experience of breast milk sub-
stitutes and food marketing.
Marketing and business literature review
The marketing review was designed to identify docu-
ments and data to describe the scale of the global breast
milk substitutes market, including current forecasting of
future directions and priorities of marketing strategies;
to identify marketing and brand strategies; and to inform
the qualitative interviews.
A range of search techniques, including snowballing, was
used to identify relevant material. Subscription business,
academic and practitioner databases were searched in
April–May 2019: Business Source Complete, IBISWorld,
Marketline Industry Profiles, Nexis, SAGE Business Cases,
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Statista and WARC (World Advertising Research Center).
Example search terms included: babies formula, baby for-
mula, baby nutrition, bottle feeding, breast milk, breastmilk,
follow-on milk, infant formula, milk powder, milkpowder,
mother’s milk substitute, mother’s milk, powdered formula,
powdered milk, toddler formula, toddler milk. A generic
search engine and the reference lists and bibliographies of
relevant reports were used to identify further market re-
search intelligence reports and global marketing materials.
Websites of the two BMS producers with the largest global
market share [18] were searched for reports and informa-
tion for shareholders, as well as marketing examples for
their brands.
The analysis of documents and secondary data was not
intended to be comprehensive; rather we aimed to update
accessible data on the scale of the BMS market and pro-
vide illustrative business and marketing strategies. The
documents and data often referred to the much broader
categories of baby and infant food and nutrition, thus
market and marketing data for the BMS category were
limited, and market research intelligence reports are still
prohibitively expensive [21]. Identified documents were
carefully scrutinised and all relevant data extracted by one
author (KA) into a project resource file. The extracted
data were organised by type (market size and forecast,
marketing budgets, marketing strategies and techniques)
for reporting findings. Noteworthy data and brand case
studies were shared among the article authors for further
analysis and use in the qualitative interviews.
Qualitative interviews
The qualitative interviews were designed to examine: how
manufacturers of breast milk substitutes position them-
selves and their products to compete against breast milk,
using a marketing framework; and how these strategies and
approaches are likely to evolve in the future. The aim was
to conduct a series of ~ 6–8 semi-structured interviews
with industry experts and professionals with experience of
marketing BMS and other commercial food products who
were willing to talk candidly about their views and experi-
ences. These included independent marketing consultants,
communications specialists and industry insiders, and those
with experience in both high and low income countries.
These interviews also involved the collection of case mate-
rials and written responses and were supported by add-
itional contextual interviews (up to ~ 10) with breast milk
and breastfeeding advocates who provided information and
advice on accessing industry informants.
All interviews were conducted either face-to-face or by
telephone, typically lasted 90–120 min and were guided
using an interview schedule which was deliberately
loosely structured to enable participants to talk flexibly
and freely about their experiences. Interviews examined
the full breadth of marketing variables (product, price,
promotion and place, commonly referred to as the 4Ps)
and how these are used to develop brands and brand
families. Links to consumer behaviour were examined in
detail. Participants were also encouraged to discuss how
BMS are currently being marketed and how this may
change or develop in the future, especially online and in
relation to digital marketing. Examples of existing mar-
keting materials generated from the literature review
were used as prompts to help stimulate discussion.
Participants were purposively selected through existing
professional and academic networks using a combination
of cascading techniques and personal recommendation,
and relied on a combination of face-to-face, telephone
and email communication, along with support from
breast milk and breastfeeding advocates. Prospective
candidates were emailed a copy of the study participant
information sheet and consent form and followed up by
telephone and/or email as required. Where appropriate,
commercial participants were offered a fixed cash incen-
tive as a gesture of thanks for their time and a contribu-
tion to any costs of taking part. All participants who
expressed a wish to take part were asked to provide in-
formed consent, either verbally or in writing. Given the
sensitive nature of the topic area all participants were of-
fered full anonymity as part of the conditions for taking
part. All interviews were conducted by two of the au-
thors (GH, DE), and for the most part with individual re-
spondents; in one instance two participants were
interviewed together. A total of 26 individuals were
approached for an interview from the UK, Continental
Europe, North America, Australia and New Zealand,
with 20 participants agreeing to take part. These in-
cluded BMS industry representatives with experience in
formula milk marketing and product development (n =
6), communications and market research consultants
with experience in food and social marketing (n = 10),
public health experts (PHE; n = 2) and breastfeeding ad-
vocates (n = 2). All of the interviews were completed be-
tween January and June 2019 and were conducted in
English with one exception (French); one participant also
provided a follow-up interview.
All interviews were recorded on digital voice-file with
participants’ consent and then professionally transcribed
and archived using non-identifiable codes prior to
analysis. Given the small number of interviews in-
volved, analysis was conducted manually by the two
authors responsible for conducting the interviews, led
by GH. The transcripts were reread repeatedly to
identify emerging themes and the reliability of these
themes reassessed by a process of cross-examination
with any interpretative differences resolved through
discussion. These analyses allowed the investigation
team to identify patterns across the data as a whole
and to draw iterative comparisons.
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Data synthesis
Data from the two research strands were reviewed by all
authors for common themes and explanations for how
the BMS marketing works and factors which contribute
to and help explain its success.
Quotes from interviewees and the marketing docu-
ments and case studies illustrate the explanations of the
marketing techniques used: consumer research, relation-
ship building, segmentation and targeting, stakeholder
marketing and promotional appeals. The market data,
budgets and strategies then contextualise these findings.
Results
Formula marketing, as for other fast-moving consumer
goods, starts with a detailed understanding of the cus-
tomer; on this can be built long-term relationships
which are strengthened with careful segmentation and
targeting. The resulting campaigns work at both a brand
and generic level. Maintaining stakeholder support is
also important. The fiscal strength of the key players en-
sure that this marketing activity is guided by the best
global expertise.
The quotations in the results section come primarily
from the interviewees with direct experience of BMS
marketing (formula marketing experts [FMEs]), but the
sentiments expressed reflect the comments of all the
marketing experts interviewed. In addition, references
are made to marketing and business documents, and in
these cases citations are included.
Understanding your customer
Marketing is a complex and sophisticated art. In the for-
mula industry, as in other consumer goods sectors, mar-
keters seek to solve their customers’ ‘problems’, and to
do so effectively it is essential to gain a detailed under-
standing of “who are you talking to, what’s in their head,
how can you engage them, how do you sell yourself to
that person” (FME). The approach is indirect, very much
“a soft sell” building faux-friendships rather than making
an overt sales pitch: “we want to build a relationship
with you as a mother, we want to support you, we want
you to see us as an ally and we want to subtly insinuate
ourselves as your friend and support in a healthy preg-
nancy and a happy baby” (FME). Paradoxically, the only
unmistakably factual material that is always included is
the ‘breast is best’ declaration required by the WHO
Code, but this is also used to good marketing effect.
First, it aligns the company with WHO and the public
health establishment. Second, it raises the topic of “first
milk”, which is supposed to be a no-go area for market-
ing: “they cannot legally communicate about the first
milk, it’s legally forbidden in most of the countries so they
are always playing with the … [requirement to] mention
that it is the best thing after the maternal milk” (FME).
For example, one company’s ‘breast is best’ statement
continues “unfortunately, not all mothers can breastfeed
…”, and so into an overt pitch for its products (see
Fig. 1).
Third it helps maintain a pretence that formula milk
does not compete with breast milk: “so they are not even
competing … they are smarter than that, they are just
saying yeah, yeah of course the milk from the woman is
the best, right, however we bring you this, this and this”
(FME). At the same time, the commercial realities are
clear: “in the ‘Baby Book’ they do track the percentage of
what they call ‘share of stomach’, that is breast milk, so
they are aware of rates of breastfeeding in a country, but
I never saw any documents or strategies anywhere that
were about how to get women away from breastfeeding. I
mean it must be. Surely, it’s in the back of their minds;
this is the free alternative that is reducing their market
share, but there wasn’t conscious recognition of that so
maybe that’s political I don’t know. Maybe the most se-
nior people, they do talk about it” (FME).
Building long-term relationships with baby clubs and
carelines
The relationship-building, its nuance and subtlety not-
withstanding, is equally strategic; well-established relation-
ships will last for years: “[corporation name] is always on
a quest to find ways to identify women who are pregnant
for the first time … right when they find out they are preg-
nant or early in their pregnancy because … how a woman
feeds her first baby is how she is likely to feed her subse-
quent babies … first time mothers are the holy grail”
(FME). Relationships can also span generations: “the music
of [brand name], Baby Love [by The Supremes], has been
there for more than forty years … so imagine your mum
heard it, now you are hearing it; that’s an iconic asset; it’s
running through generations” (FME).
Baby ‘clubs’ (Fig. 2) and telephone advice lines are the
favoured vehicles for establishing and fostering these rela-
tionships: “we had a particular focus on what they call
‘one to one marketing’ which is reaching mothers individu-
ally and building individual relationships with mothers.
The two big tools in their arsenal, their two favourite tools,
were the [telephone advice line] and the [baby club] … I’d
spend a lot of time advising marketing teams [in different
countries] that the first two things you do are set up your
[baby club and telephone advice line]; you can then do
other things, but those are the two direct relationship
building [tools] with mothers; those are the two ace cards
to play”. And it is still very much a soft sell: “there is no
mention of formula on the [telephone advice line], it’s just
about insinuating the products as your friend”.
Digital technology has greatly enhanced these tools: “I
have decks and decks of the different apps and digital
things that [corporation name] created. Basically, their
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process was to ask in a given country what kinds of
mothers are we talking to, what are the needs that those
mothers have, and therefore what digital marketing do
we create to meet those needs” (FME). These apps range
from “an online ovulation calculator, to help women get
pregnant in the first place” to “an app for mothers to
reach other mothers who were up all night, so mothers
who have a newborn baby and they are up at three am
and they are lonely and bored, could connect to other
mothers who are up at the same time and have a chat”
(FME). Similarly, “when you sign up to the [baby club]
you tell them what your due date is and whether you are
at two months or eight months or wherever you are, and
then you step into a series of emails that are timed to
your stage of pregnancy” (FME). In return for this tar-
geted support, the company gets a constant stream of
personal data as well as enhanced sales: “they had
significant evidence to show that these are effective at
driving sales literally … they had very good evidence to
show that if a woman is in the [baby club], if a woman
has called the [telephone advice line], there is a signifi-
cant correlation with her ultimately buying [corporation
name’s] products” (FME).
Segmentation and targeting
This type of bespoke marketing means that one size will
not fit all. The personal data are therefore used to seg-
ment customers into smaller, more homogenous target
groups which then receive suitably honed approaches:
“so, globally, [corporation name] target basically three
kinds of mothers, and this is true in every country, so they
call them Blue, Yellow and Red mothers (Fig. 3) … speak-
ing of segmentation there’s your big three global categor-
ies” [FME]. In western countries, for example, the
“Breast milk is the ideal nutrition to ensure babies get the best possible start in life. It provides infants 
with the right nutrients, builds tolerance and offers protection, while, for mothers, it fosters bonding 
and stimulates the production of important hormones.
Unfortunately, not all mothers can breastfeed: there are a few medical conditions that aren’t 
compatible with breastfeeding. Also, situations such as inflexible work schedules or working away 
from home may prevent a mother to breastfeed her baby. They simply are not in a conducive 
environment to breastfeeding.
Studies have shown that non-breastfed babies are often given alternatives which don’t offer the 
nutrition they need. So it is critical that, when infants are not breastfed, they receive the highest 
quality, scientifically proven alternatives to breast milk with the appropriate guidance of their 
healthcare professionals. For us, the number one priority is to ensure that all children get the best 
possible nutrition.” [23]
Fig. 1 Breast is best, but [23]
Aptaclub: “Your baby’s future health begins here!  At Aptaclub, we believe that 
experience helps to build resilience; that each new encounter, whether in 
pregnancy or after birth, can shape your baby’s future development. With our 
scientific expertise and one-to-one round the clock support, we can help you 
and your baby embrace tomorrow. Join Aptaclub.” [24]
“Welcome to C&G baby club: It’s free to join and offers loads of friendly advice 
and info, from bump to mum! You’ll get weekly emails with tips for your stage 
and goodies in the post! Join now.” [25]
Blédiclub: “4 good reasons to join: special offers; gifts and benefits; live chat 
advice; personalised newsletter.” [26]
Join Similac® StrongMoms® “Rewards for: Similac coupons; formula samples 
and expert nutrition guidance.  Up to $400 in benefits.” [27]
Fig. 2 Baby Clubs [24–27]
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market principally comprises Blue and Yellow mothers,
and there is a clear difference in the type of advertising
they receive. Blue mothers (and fathers) get reassuring
technical claims and promises about their child’s future
from “our most advanced formulation yet” (Fig. 3): “‘in-
spired by forty years of breast milk research’, that’s a very
clever claim, which essentially doesn’t mean anything
technically, but which is a very clever way to imply to re-
duce guilt about not breastfeeding” … “That is a bang on
for Blue mothers, ‘their future starts today’, she (mum)
absolutely believes that” (FME). Meanwhile, for Yellow
mothers the pitch is to “nourish their happiness” (FME)
backed up by lots of gurgling, happy babies doing
endearing things. The call-outs for the baby clubs (Fig.
2) epitomise these distinctions.
Again, this is strategic: target groups do not just get
their own advertisements, they get their own brands,
each backed by multifaceted marketing effort. New
product development, such as ‘follow-on’ milks, ‘special-
ist’ formulas, or, the “BabyNes for It Moms baby nutri-
tion system” (an espresso-like machine which uses pods
to deliver “the exact perfect dose of milk for your baby”)
[28], keeps the category vibrant, and in the case of spe-
cialist formulas, builds useful links with the medical es-
tablishment (see below). Point of sale display in both
pharmacies (for associations of quality and medical re-
spectability) and supermarkets (for associations of value)
ensures ready access. Pack design reinforces brand values
and links first milks with other products. (See for example,
p.35 of Harris et al. for images [29].) All of this brand sup-
port is vital because “it’s brands that give things meaning,
… it’s a short cut for communication, it bestows white pow-
der with meaning that attracts a certain kind of woman
and gets her to buy it” (FME). They give product and com-
pany a human face, a personality, a story to tell; and the
sales pitch remains subtle, it is possible to “create a brand
affinity without mentioning product” (FME).
This makes regulation extremely difficult: “When [corpor-
ation name] market infant formula they do need to tiptoe a
bit around stuff before 12 months [promoting formula for
babies under 12 months is supposed to be prohibited], but
they still do all sorts of things. They don’t talk about product
at all, it’s like, ‘Call our [telephone advice line]’, ‘Join our
[baby club]’, no mention of a product, so you can still mar-
ket without talking about a product” (FME).
Generic effects
Formula promotion also has a generic effect, as an
award-winning campaign from a US multinational dem-
onstrates (Fig. 4). A dramatic rise in US breastfeeding
rates was identified as a threat, and this was being exac-
erbated by negative media coverage about BMS. As a re-
sult, the brand was being undermined. An advertising
agency was therefore commissioned to “reinvigorate the
Similac brand” and also “change the face of an entire in-
dustry” [30]. The result was the “Sisterhood of Mother-
hood” campaign using the formula trope of “doing what’s
best for baby” [30]. At its core is a video showing a
group of parents arguing in a public park, criticising
each other for their choices and differences (about nap-
pies/careers/sexuality/gender/feeding) but when one of
the buggies (strollers) runs away down the hill they stop
fighting and become united in their instinct to save the
baby, which, with palpable relief, they succeed in doing
[31]. The strapline then appears: “no matter what our
beliefs, we are parents first – welcome to the Sisterhood
of Motherhood”. It “was the most successful campaign
ever for Similac” resulting in increased sales and vastly
improved media coverage [30]. It also succeeded in
changing the narrative about infant feeding, which is no
longer a matter of scientific evidence, but lifestyle
choices and beliefs. Breastfeeders are positioned as just
one minority, with one set of beliefs.
Blue: “are mothers who are all about ambition, they are about raising a capable, healthy, happy baby, these are 
the mothers who would be booking this baby into nursery school when the baby is six months old, they are 
already looking for the right university, I mean this baby has after-school tutors, the mother is thinking very hard 
about getting everything right so that this baby has a happy and healthy life, hopefully a successful, middle 
class future, and so everything that she does is about optimizing baby’s future prospects. Those are Blue 
mothers; [brand name] is aimed at these mothers.”  Key marketing slogans: “our most advanced formulation 
yet”; “inspired by forty years of breast milk research”; “their future starts today”.
Yellow: “so [for] Yellow mothers it’s all about happiness, so success to her is a giggling baby, if the baby is 
happy she is happy, it’s about creating a loving, happy home for that baby to bloom and be content. You can 
see that in [brand name]. I can show you a [brand name] ad that is bang on Yellow mothers, it’s called the 
‘giggling baby’s’ ad and it is literally just babies giggling, it’s adorable and it’s what those mothers want, yeah.”
Red: “things that Reds do are aimed at enhancing the sense of happy, cocooned childhood, so Red brands 
would do things like you know give you, you sign up for our baby club and we will send you a baby book so that 
you can keep your precious memories of you and your baby and your family. It’s just anything that enhances 
that sense of safe cocooning, safe environment.” (FME)
Fig. 3 Global Market Segmentation: Blue, Yellow and Red Mothers
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Cognitive dissonance
This conceit that breast and bottle equate may help ease
dissonance among formula marketers: “everyone ‘drinks
the Kool-Aid’ that it’s a good thing, it’s based on breast
milk research, it’s fairly genuine from the inside. No, I
don’t think anyone thinks about it as reducing rates of
global breastfeeding, most people come from commercial
marketing backgrounds in which you sell software, you
sell sausages, oh we are selling baby food, fine …” (FME).
But, it does not entirely remove the disquiet: “So, did I
have qualms at the time? No. Would I go back to it? No,
I wouldn’t” (FME). The change of heart comes from ex-
ternal stimuli (in this case participating in the study
played a role), not the industry: “Nowhere is there men-
tion of that within [corporation name] there is no sense
that you know we are basically selling tobacco, there is
no, there is no consciousness of that that I detected … I
don’t think we would have worked in it if we thought we
were doing something evil” (FME).
Targeting the medical establishment
The industry takes care to keep external stimuli support-
ive by building strong financial and educational links with
the medical establishment: “It creates a normality when
the Royal Colleges [two names] that lay out the infant
feeding guidelines, and set policy [in the UK], and set the
standard, and create leadership culture … both now have
relationships with [two corporation names]. It sanitises it,
in my view, it’s a brand sanitiser, where we have key opin-
ion leaders, Royal Colleges, our leading paediatric institu-
tions in terms of hospitals [two names] all having
comfortable and cosy relationships with infant formula”
(PHE). The principal vehicle for this stakeholder market-
ing is ‘specialist formula’: “The Royal College is very clear
that it only accepts money for specialist formula, it doesn’t
accept money for general formula. Now the [WHO] Code
is also very clear about the marketing of breast milk substi-
tutes, and that these specialist formulas are definitely
breast milk substitutes, and they normalise interactions
between industry and the profession” (PHE). The medical
profession can also provide a means of circumventing
regulation, as another prize-winning campaign explains:
“Mead Johnson communicated the benefits of its Enfa A+
Gentlease baby formula directly to doctors, to work around
advertising regulations in the Philippines … The approach
resulted in 40% sales growth after three months” [32].
More fundamentally, there was unease about commerce
intervening in such a profoundly human area: “the first key
moment [of pregnancy]”, “the departure point”, is “really
not addressed by anybody except the brands” (FME). The
search for competitive advantage can also be disturbing:
“one I find awful, in Indonesia, that they are already
enriching the milk to help develop the brain even more be-
cause [customers] really feel that from childhood [their
child] needs to have more, more, more; this I found very
tricky … it is going too far you know?”; “In [corporation
name], the next big innovation was epigenetics, so the
whole idea that a baby’s success starts very early and that
genes change generation to generation, so if there are
stresses in the environment, that’s encoded in genes. But
basically it’s saying you need to be concerned about your
baby, not just from birth but from way before birth. And I
think the next thing they were going to promote with
[brand name] is that it appeals to epigenetics in some way
as well, which is very Blue mother. That’s what they were
planning; … that was the next big thing coming down the
pipeline” (FME). A 2016–17 multimedia campaign for a
follow-on milk in Indonesia, is explained as addressing the
The Problem: an industry and a brand in trouble
“according to the Centers for Disease Control and Prevention, breastfeeding rates in the United States increased dramatically 
from 24% to 79% between 1971 and 2011. In that time, the formula industry has come under fire from media and parents who 
question their products’ benefits and wonder if companies really have parents’ and babies’ best interests in mind.” [30] “Similac 
brand was at a minuscule 13% positive [media and blogger coverage], and was primarily focused on topics related to scientific 
issues, GMOs [genetically modified organisms] and potential toxins, with headlines stating ‘5 Hidden Toxins Found in Your 
Baby Products’ and ‘Get Out from Under the Influence of a Lifetime of Formula Marketing’” [30].
The Creative Solution: emotional support for mothers
Research showed that mothers felt judged by others for their parenting decisions causing them “to feel stressed, angry and 
inadequate”; but when supported, “90% of moms felt more confident, more relaxed, happier and more fulfilled”.  A video was 
devised to launch the Sisterhood of Motherhood [31]: “a social community that embraces encouragement, not judgment” and “a 
common sentiment: doing what’s best for baby” [30].
The Campaign: digital reach
“Knowing that historically media were unreceptive and intensely negative about messages from Similac and other formula 
companies, our media strategy focused on seeding an exclusive for the video and campaign with a top national media outlet 
[The Huffington Post], in hopes that this positive coverage would set the tone for all media responses” [30].
The Outcome
“The Sisterhood of Motherhood was the most successful campaign ever for Similac and the first equity-based campaign for the 
brand.”  Sales increased by 2.2%; Similac brand rose from 13% to 93% positive media coverage (year-on-year); and gained 
120,724 new Facebook friends [30].
Fig. 4 The sisterhood of motherhood [30, 31]
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“sceptical consumer” by launching “the Bebelac Grow
Them Great Campaign to talk about Bebelac's functional-
ity story”; that the formula delivers “benefits such as [a] de-
veloped brain, good digestive system and well-rounded
child” [33].
Fiscal power
Market size and forecast
Processed food production in the global market is domi-
nated by a handful of powerful multinational corporations.
Nestlé (US$19,370m brand value) and Danone (US$9098
m brand value) were ranked globally by Brand Finance as
the two most valuable food brands in 2018 and ranked by
Kantar Worldwide in 2017 as 13th and 19th, respectively,
for household reach among the leading fast-moving con-
sumer goods brands worldwide [34]. The global dairy in-
dustry generated sales of US$204.4bn in 2017, based on
Rabobank data from the 20 leading dairy corporations
[34]. BMS products are just one category within a huge
portfolio of products these global corporations produce.
Data from 2015 demonstrated that six multinational
corporations controlled more than half of the global baby
food market (including BMS), Nestlé followed by Danone
holding the biggest shares, and Kraft Heinz, Mead
Johnson, Abbott and FriesslandCampina the remaining
four (Euromonitor International, 2015, as cited by Save
the Children [18]). In 2015, Euromonitor International
valued global BMS retail sales at US$47bn globally and
Nestlé as the lead company accounted for 22% of these
global sales [35]. Forecasting by Euromonitor for the
WHO, based on the upward sales trajectory and market
research to 2014, predicted that global sales would be
worth US$70.7bn by 2019 [11]. Another, more conserva-
tive, estimate for investors by a multinational vegetable
fats producer using 2016 Euromonitor data suggest the
global retail value will be US$62.5bn by 2020, and breaks
the forecast down by category: 29% standard formula (0–
6months), 21% follow-on formula (6–12months), 43%
toddler formula (> 12months) and 7% special formula
(e.g. premature and allergy) [36].
Marketing budgets
The marketing budget data we identified are from dis-
parate sources and we concur with Piwoz and Huffman
on the difficulty of finding open access comprehensive
or verifiable data on how much money companies spend
to market BMS products [14]. Overall annual advertising
expenditure in 2018–19 for the two companies holding
the largest portions of the global baby food and drinks
market was US$944.5 m for Nestlé USA, Inc. (Glendale,
CA) for national advertising expenditure that included
above-the-line advertising channels plus sponsorship
[37], and US$1143.3 m for Groupe Danone S.A. (Paris)
for traditional media advertising, direct mail, point of
purchase and product samples [38]. Another business
data source described the US Mead Johnson Nutrition
Company as one that markets its BMS and children’s
nutrition product lines to both parents and health care
professionals in Asia, Europe, Latin America and North
America. The company spent $223.8 million on advertis-
ing on “TV, print, and other consumer media, with an
increasing focus on social and other direct media in
2016, up from $206.2 million in 2014” [39].
Older Nielsen data, from 2015, breaks down advertising
spend by Nestlé SA in the USA, as US$5.58m on advertis-
ing infant formula and US$4.01m on toddler milk [29].
Abbott spent US$3.36m advertising infant formula and
US$20.71m advertising nutritional supplements in the
USA in 2015, and Mead Johnston Nutrition spent
US$12.82m advertising toddler milk and US$0.81m on
infant formula [29]. Overall, US$9.75m were spent on ad-
vertising infant formula and US$16.83m on advertising
toddler milk in the USA in 2015, mostly on television and
in magazines [29].
In the UK, Nielsen data show that £13.2m (approx.
US$16.1m) was spent on advertising BMS in 2018 using
traditional media channels (which excludes sponsorship,
search and social advertising channels), up 12% from the
previous year but 23% lower than in 2015 [40]. BMS adver-
tising comprised 80% of the total advertising expenditure
for baby food and drinks [40]. Further analysis of Nielsen
advertising data by Mintel, showed that Danone (the UK
market-leader in sales value and volume) spent £13.4m on
baby food and drink (including BMS), and spent more ad-
vertising its follow-on milks (83% of spend) than other in-
fant formula brands. As the analysts note later in their
report, “The key to growth will be in keeping older toddlers/
pre-schoolers buying into the category [baby food and drink]
for longer, if the birth rate continues to decline”. Advertising
spend by Nestlé in the UK in 2018 was far lower (less than
£0.1m), a “dramatically reduced” spend from the historic-
ally major spender [40].
Profit margins and pricing strategies
An analysis of company reports from five of the biggest
baby food companies gave an indication of the profitabil-
ity of the broader baby nutrition category. A 23.3%
weighted average of profits demonstrates why investors
are interested in the category [18, 41]. Some business
analyst reports described BMS products as “high-margin”
categories, alongside pet food and premium coffee (e.g.
by Business Monitor International [42]).
Companies have taken the opportunity to premiumise
their BMS products. In an investor seminar presentation,
Danone endorsed their brands and strategies for mid- to
long-term growth drivers in the Chinese market, includ-
ing Aptamil Classic, Nutrition Classic and Aptamil Plat-
inum, as being “well suited to address untapped
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opportunity in ultra-premium IMF [infant milk formula]
segments”, divided into pricing segments described as
“mainstream … super premium … ultra-premium …
[and] ultra-premium+” [43]. Similarly, in 2017 Mead
Johnson describe their ‘routine’ infant formula products
and their ‘premium-priced’ product, the latter intro-
duced into “certain geographies” (for the United States
‘Enspire’, and in China ‘Enfinitas’) with innovative com-
ponents alleged to be “naturally found in human breast
milk [to] provide important benefits (lactoferrin to sup-
port immune health and MFGM [Milk Fat Globule
Membrane] to foster cognitive development)” [44].
Global reach
Other global stakeholder companies include, for example,
the suppliers of supplementary ingredients and packaging
to the BMS industry. One US firm has agreements to sup-
ply docosahexaenoic acid to almost 30 BMS manufac-
turers that market products in more than 75 countries
[45]. A packaging firm in Sweden, with 15 production sites
in ten countries, counts the BMS industry as key cus-
tomers of their “high-performance barrier packaging solu-
tions … to protect and promote the content” [46].
The size and global reach are viewed by business ana-
lysts as an asset. The acquisition of Mead Johnson Nutri-
tion Company by Reckitt Benckiser Group Plc in June
2017 “supports future growth operations and expansion
plans in various developing markets such as China,
Vietnam and the Philippines and in various other parts
of Latin America region” [47]. Through Mead Johnson’s
Enfamil brand (infant formula, children’s nutrition, and
other nutritional products) and Nutramigen brand (spe-
cialty formula products) the company markets and sells
approximately 70 different products to mothers, health
care professionals, and retailers in 50 countries in Asia,
North America, Latin America, and Europe [47].
Analyses funded by the WHO have estimated the car-
bon footprint, as greenhouse gas emissions, from the
production, emissions from transport and in-home ster-
ilisation of bottles, and preparation of powdered BMS
targeted at infants of 0–6 months to be consistently
higher than that for breastfeeding in all the countries
tested [48]. Breastfeeding’s carbon footprint included
carbon cost of the additional food required to maintain
the mother’s energy balance while breastfeeding. The
WHO have also cited USA data for the vast tonnage of
single-use BMS packaging (plastics, cans, metal and
paper) that ends up in landfills [11]. Some of the most
popular BMS products in the USA are ready-to-feed
single-use plastic bottles of formula with teats.
Lobbying power
Marketing to policy makers by “treating government de-
partments as discrete markets to be targeted and sold to,
as well as understanding the culture and buying process,
… [using] public affairs departments … to influence gov-
ernment and to create good relations with them” is part
of a corporate strategy [49]. There is an imbalance of
government fiscal policies in many countries that have
incentivised families to use BMS rather than to breastfeed
[50]. These have included government-subsidised BMS
products provided through community welfare programs
and BMS companies providing health workers’ education
and training within countries’ hospital and public health
frameworks. Further, partnerships between the BMS
industry and government are increasingly proposed as so-
lutions to infant and child food security issues [51]. Evi-
dence of commercial stakeholders in the BMS industry
influencing local policies for infant feed practices has been
reported in several countries [14], and more recently in
the USA, lobbying by industry stakeholders intensified be-
fore a meeting of the WHA in 2018 [52].
Discussion
This small-scale study, in which we analyse how formula
marketing and its key components work, is based on in-
terviews with practitioners, some of whom have worked
within the industry, and a review of secondary sources
which detail business methods. Previous studies have de-
scribed formula marketing and tried to unpick its impact
on behaviour; to our knowledge ours is the first investi-
gation to look underneath the hood and examine how
the engine works. We have also assessed the size and
power of the Formula Industry, to provide an indication
of the resources it has at its command. The results make
uncomfortable reading.
New parents are often extremely vulnerable; raising a
baby is immensely challenging, and almost all parents
are primarily motivated by doing the ‘best’ for their child
in whatever circumstances they find themselves. They
badly need reassurance and support. They also need a
convenient and dependable way of feeding their child: a
healthy diet compatible with hectic modern life, and the
norm of working mothers and fathers. Formula compan-
ies have developed an intimate understanding of these
needs and are delivering to them with a combination of
‘sympathetic’ relationship building, non-judgemental
support, individually targeted communications, a readily
available range of reliable products and the construction
of reassuringly familiar and evocative brands. Digital
marketing, where the social and commercial have
melded, is greatly enhancing their efforts, whilst making
the breadth of industry marketing strategies increasingly
difficult to track and document.
The reach and wealth of the multinational corporation
has turned this soft power into a very hard global force.
The BMS market is worth about US$70bn per annum and
is controlled by six of the most powerful food companies
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in the world, with massive household and global reach.
High profit margins offer attractive investment and busi-
ness opportunities. Marketing spend is extremely difficult
to quantify accurately but certainly runs into billions of
dollars annually, which is used to target governments and
stakeholders as well as consumers. This is corporate mar-
keting at its most powerful and disturbing.
The concerns are twofold. First, in most cases, formula
feeding is not the best option, from a health or ecological
standpoint. As noted above, its use is causing immense
harm to babies, mothers and the environment. Second,
the marketing is built on deception. Infant formula is in
reality the definitive one-size-fits-all product. By law all
products must have the same formulation, as established
by independent research. The only permitted variation
from this is for unproven additives, which if they ever
prove to be beneficial, would, again by law, have to be
added to all formula products. The product ranges, the
segmentation and bespoke targeting, the carefully honed
brands are simply subterfuge. In the UK the two leading
and supposedly very different brands which dominate the
market are in fact made by the same multinational.
This study was limited to a small number of interviews
and relied on access to secondary data, mostly from
high-income economy countries. Thus it is not represen-
tative and in particular reveals less than we would like
about what is happening in the global south. Nonethe-
less, it provides key insights into how infant formula
marketing works, and adds to our understanding of how
international business impacts ill-health [53].
Conclusions
There is an urgent need to shed more light on the harm
being done by infant formula marketing; its extent is
revelatory to all but a small group of public health ex-
perts. Even the marketing practitioners who had worked
in the industry were taken aback by it and began to ex-
press overt regrets about their past actions. Just as for-
mula is being normalised, so too is formula marketing.
Corporate marketing careers move between companies
and sectors – from formula to supermarkets to tech –
this unthinking and completely unwarranted moral
equivalence has to be challenged. The medical establish-
ment has also been pulled into this charade; just as fifty
years ago it had to rethink tobacco, so today it needs to
review fundamentally its relationship with the formula
industry. The recent decision by the BMJ and sister jour-
nals to refuse infant formula advertising is a welcome
move in this direction [54].
The regulation of marketing needs to be greatly
strengthened; as one marketing practitioner observed:
“the most effective response would be to prohibit any for-
mula marketing at all; much like is done with tobacco”
(FME). The point is well-made, but formula is not
tobacco; it can be an essential option in specific circum-
stances – with preterm or SGA (small-for-gestational-
age) infants, for instance, or when, even with optimal
support, breastfeeding proves impossible. The problem
is not the product but rather out-of-control marketing,
which is driving dangerous over-consumption in the in-
terests of corporate profits. This needs to change. The
sole purpose of communications about formula should
be to help parents and carers make the best possible de-
cision for the baby. Advertising does nothing to help in
this regard. It promotes spurious product differences
and reinforces these with confected brands. In its digital
form, which has become so prominent in recent years, it
is particularly manipulative. All this advertising should
cease forthwith, as demanded by the WHO Code four
decades ago [16]. The pack should be unbranded and
become a platform for objective guidance, from an
accredited public health source, explaining the product
contents, how it should be used and by whom. Point of
sale activity should add further health promotion sup-
port, again from an independent source. Pricing also
needs be tightly regulated; infant formula is immensely
profitable for a small number of multinational corpora-
tions, while the costs to society are enormous. In
addition, it should no longer be possible to use price as
a bogus indicator of quality.
Only with these radical revisions will we get an infant
formula market that serves the needs of babies and their
parents rather than shareholders. They are big steps that
will take careful, sustained management and will meet
resistance from very powerful vested interests. In other
contested fields, where radical change is needed, such as
tobacco and climate, a Framework Convention, with its
global reach, has provided the answer [55]; the equiva-
lent is now needed for infant feeding.
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